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Immunoglobulin G4-related disease (IgG4-RD) is a chronic disease that presents with inﬂammation and
ﬁbrosis of involved tissue. It encompasses several disorders previously described using different terms,
but all disorders are characterised by IgG4-positive plasma cells and lymphocytes inﬁltration of tissues.
We report a rare case of a 58-year-old man with IgG4-related pleural disease without other systemic
manifestations. The diagnosis was based on characteristic changes on PET-CT and typical histopathology
in a pleural specimen. The patient’s condition improved following immunosuppressive therapy.
© 2016 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Immunoglobulin G4-related disease (IgG4-RD) is a relatively
new entity. The clinical symptoms are vague and nonspeciﬁc and
early diagnosis is therefore challenging. Tissue inﬁltration with
IgG4-positive plasma cells and lymphocytes is characteristic [1] and
elevated serum levels of IgG4 are also common. The formation of
chronic ﬁbrosis and inﬂammation may occur in nearly every organ
although the most frequently affected are the submandibular
glands, lymph nodes, orbit, pancreas, retroperitoneum, lungs and
parotid glands [2]. The epidemiology of the disease remains poorly
described and literature is scarce on the global incidence and
prevalence of IgG4-related diseases [3]. We report a rare case of
IgG4-RD with isolated pleural involvement.2. Case report
A 58 year-old man was referred due to IgG4 related pleural
disease. He presented two years earlier with unexplained weight
loss. He had no dyspnoea, cough or chest pain. He did not report
fever, night sweat or any other symptoms. He denied allergic
rhinitis or asthma. His brother suffered from asbestos-triggered
pleural plaques but he had no family history of collagen orewska).
Ltd. This is an open access article uautoimmune disease. In his youth, he used to work as a blacksmith
where he was exposed to dust and fumes from welding as well as
asbestos. Number of asbestos ﬁber-years was low according to an
evaluation by specialists in occupational medicine. In the last 20
years prior to admission he worked as a salesman and environ-
mental consultant in agriculture. He was an ex-smoker (2 pack
years). He reported to have an active lifestyle.
During admission he had grade 2 dyspnoea according to the
Medical Research Council dyspnoea scale, but still no cough or
sputum. His physical examination was normal. Lung function was
reduced: Forced vital capacity (FVC) was, 56% of the predicted;
forced expiratory volume in 1 second (FEV1) was 57% of the pre-
dicted; FEV1/FVC ratio was 0.8; total lung capacity (TLC) was 72% of
predicted and diffusing capacity for carbon monoxide (DLCO) was
74% of the predicted. Electrocardiography and echocardiography
were normal. Laboratory examinations showed a normal peripheral
white blood cell count (8.25  10^9/L), C-reactive protein (4.4 mg/
L), albumin (37 g/L), lactate dehydrogenase (175 U/L), haemoglobin
(8.5 mmol/L). Total serum IgG was normal, 12 g/L but sIgG4 was
increased, 1.410 g/L (0.039e0.864 g/L).
A PET-CT scan showed FDG uptake in pleura, mostly on the right
side with bilateral pleural thickening and calciﬁcation (Fig. 1). Due
to the suspicion of a mesothelioma, a pleural biopsy was performed
and the suspicion of a malignant lesion was ruled out. Histology
revealed chronic ﬁbrotic inﬂammation and inﬁltrationwith plasma
cells, characteristic for IgG4-related disease. A storiform pattern
and an obliterative phlebitis were also present. The number ofnder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. PET-CT showing pathological changes of the pleura before the immunosup-
pressive treatment.
Fig. 3. Immunoglobulin G4 immunostaining showing IgG4 positive plasma cells.
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(HPF) with IgG4þ/IgG plasma cell rate of 50% (Figs. 2 and 3). An
elevated IgG4-positive to IgG-positive plasma cell rate greater than
30% is helpful in distinguishing IgG4-related from non-IgG4related
inﬂammatory conditions [4]. The number of IgG4þ plasma cells
over 50 per HPF is found to be highly speciﬁc. In conclusion IgG4-
related pleura disease was considered the most likely diagnosis.
The patient started treatment with prednisolone 37.5 mg per
day, gradually tapered over time. Follow-up PET-CT showed ﬁrst
good response to the treatment (Fig. 4), and then progression of
ﬁbroinﬂammatory changes during prednisolone tapering. Gluco-
corticosteroid therapy was continued with prednisolone, 7.5 mg
per day, and added azathioprine 50 mg bid. Azathioprine was dis-
continued due to gastro-intestinal side effects. Instead, metho-
trexate 15 mg weekly was found to be a good alternative asFig. 2. Immunoglobulin G immunostaining showing IgG positive plasma cells.maintenance therapy. The patient has now been stable for one year
with a combination of prednisolone with temporary increase of
dose and immunomodulating treatment.3. Discussion
IgG4-related disease is a ﬁbroinﬂammatory condition charac-
terised by a tendency to form tumefactive lesions, a dense lym-
phoplasmacytic inﬁltrate rich in IgG4-positive plasma cells,
storiform ﬁbrosis, frequent but not invariable elevations of serum
IgG4 levels, and a swift initial response to glucocorticoids provided
that tissue ﬁbrosis has not supervened [5]. This diverse entity can
affect nearly every organ and systemic manifestations usually occur
[6]. Few cases of extensive multiorgan involvements have been
published [7,8]. Isolated IgG4-pleuritis has been described in onlyFig. 4. PET-CT showing complete remission of pleural activity after high dose
prednisolone.
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an isolated IgG4-RD pleural involvement presenting with bilateral
pleural thickening and calciﬁcation without pleural effusion.
Nonspeciﬁc clinical signs such as weight loss and slowly worsening
of dyspnoea suggested malignancy. Bilateral pleural biopsy and
right-side pleurectomywas necessary to achieve relevant specimen
and exclude malignancy. Histopathological diagnosis demands
differentiation from desmoplastic mesothelioma and inﬂammatory
myoﬁbroblastic tumour. According to consensus statement, a his-
topathological diagnosis of IgG4-RD requires two of the following
major features: Dense lymphoplasmacytic inﬁltrate, ﬁbrosis ar-
ranged at least focally in a storiform pattern, and obliterative
phlebitis [11]. These features were all present in the biopsy thus
conﬁrming the diagnosis of IgG4-RD-pleuritis.
The imaging diagnostics also presented with a classical picture
of the disease. PET-CT is an accurate tool for detecting IgG4-RD-
related lesions as the levels of FDG uptake reveals the activity of
those lesions [12]. It is also found to be the best tool for follow-up
on disease progression. In our case it helped to notice immediate
response to systemic steroid therapy as well as relapse of inﬂam-
matory changes after discontinuation of treatment.
Increased serum IgG or IgG4 level can help conﬁrm the diag-
nosis but is not speciﬁc enough for disease and therapymonitoring.
Classic IgG4-RD can be active in the absence of elevated serum IgG4
concentrations and not all patients with IgG4-RD have an elevated
serum IgG4 level at baseline. Many patients have a substantial
decline in serum IgG4 concentrations following treatment, but
some never normalise [13].
IgG4-RD Responder Index (IgG4-RD RI) has been developed and
may be a helpful tool in follow up of the disease. It permits
objective quantiﬁcation of the treatment response by providing
standardised outcome measures and may be used by physicians
during clinical visits [14].
Systemic corticosteroids are thought to be the ﬁrst line treat-
ment; in some cases the use of immunomodulating agents such as
azathioprine or methotrexate are required [15]. Alone or in com-
bination with B-cell depletion with rituximab, prompt clinical
improvement can be obtained. Nevertheless, treatment discontin-
uation usually leads to quick relapse of IgG4-pleuritis [6,16]. Our
case reﬂects the typical response to the applied treatment. How-
ever, further research in this ﬁeld is needed, especially in relation to
cases with mono-organ affection, where systemic therapy is often
associated with side effects.
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